Small molecule may disarm enemy of cancer-fighting p53
Tuesday, December 7, 2010 - 16:30
in Health & Medicine
A pioneering clinical trial is testing the effectiveness in leukemia of a small molecule that shuts down MDM2, a protein that can disable the well-known tumor suppressor p53.